NCT02151084 2025-12-16
A Study of Different Dosing Schedules of Selumetinib With Cisplatin/Gemcitabine (CIS/GEM) Versus CIS/GEM Alone in Biliary Cancer
University Health Network, Toronto
Phase 2 Active not recruiting
University Health Network, Toronto
St. Olavs Hospital
University of California, San Diego
Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
Columbia University